Clinical trial NCT05676359: Knowledge of Living Will in Patients With Rheumatic Diseases
Official title: Knowledge of Living Will in Patients With Rheumatic Diseases. A Case-control Study
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Rheumatic Disorder
Keywords: Rheumatic diseases
living will
Lead sponsor: National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Sponsor class: OTHER
First posted: 2023-01-09
Enrollment: 157
Sex: ALL
Minimum age (years): 18
Maximum age (years): 100
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients will be selected from those attending the Department of Immunology and Rheumatology in Mexico City outpatient department, and the controls will be patients´ relatives of the same sex, age ± five years and who are known to be healthy

Brief summary: The living will is a legal document derived from a communication and deliberation process, medical ethical aspect, currently regulated in Mexico by the General Health Law and the Health Law of Mexico City.

Knowledge of living will in the population with chronic diseases, including rheumatic diseases, has been little addressed. Most patients do not know what the living will document is, so they do not carry it out and others, despite knowing it, have a passive attitude toward doing it.

Detailed description: A study will be carried out on patients with rheumatic diseases and healthy family controls. Patients will be selected from those attending the Department of Immunology and Rheumatology in Mexico City outpatient department, including consecutive cases.

The patients will be assessed for their quality of life and disability. Patients and controls will be evaluated on the knowledge of living will, their perceptions about specific health outcomes, sociodemographic characteristics, comorbidities, and psychiatric pathology.

Eligibility criteria: Inclusion Criteria:

Cases

* Patients with a rheumatic disease diagnostic by a rheumatologist
* Patients with rheumatic diseases attending the Department of Immunology and Rheumatology in Mexico City outpatient department
* Patients who agree to participate in the study, who complete and sign the informed consent Controls
* Relative of a patient with rheumatic diseases of the same sex and age ± 5 years, without known rheumatic and/or chronic disease and without the use of pharmacological treatment for more than 7 days during the month before study entry.

Exclusion Criteria:

Cases

* Patients with severe diseases or in palliative care by a rheumatologist

Controls

- Withdrawal of the study

Primary outcomes:
measure: Knowledge of the living will with the living will questionnaire (locally development)
timeFrame: 1 day At study inclusion (After their rheumatology consultation)
measure: Perceptions of Health Outcomes with the perceptions of health outcomes questionnaire (locally development)
timeFrame: 1 day At study inclusion (After their rheumatology consultation)
Secondary outcomes:
Other outcomes:
Locations:
city: Mexico City
country: Mexico
facility: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Study officials:
affiliation: National Institute of Medical Sciences and Nutrition, Salvador Zubiran
name: Virginia Pascual-Ramos, Dr.
role: PRINCIPAL_INVESTIGATOR
References: